Biomarin Pharmaceutical Inc (BMRN.O, BMRN US) Investment Opportunity 提高FGFR标准: 低软骨发育不全3期VOXZOGOData具有竞争力，AGV和功能改善强劲且Safety良好 Please enable JavaScript to view full opportunity details. Back to Recommendations View Reports